353 related articles for article (PubMed ID: 34671863)
1. Recent applications of quantitative systems pharmacology and machine learning models across diseases.
Aghamiri SS; Amin R; Helikar T
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):19-37. PubMed ID: 34671863
[TBL] [Abstract][Full Text] [Related]
2. Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.
Bai JPF; Earp JC; Pillai VC
AAPS J; 2019 Jun; 21(4):72. PubMed ID: 31161268
[TBL] [Abstract][Full Text] [Related]
3. Review of applications and challenges of quantitative systems pharmacology modeling and machine learning for heart failure.
Cheng L; Qiu Y; Schmidt BJ; Wei GW
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):39-50. PubMed ID: 34637069
[TBL] [Abstract][Full Text] [Related]
4. Two heads are better than one: current landscape of integrating QSP and machine learning : An ISoP QSP SIG white paper by the working group on the integration of quantitative systems pharmacology and machine learning.
Zhang T; Androulakis IP; Bonate P; Cheng L; Helikar T; Parikh J; Rackauckas C; Subramanian K; Cho CR;
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):5-18. PubMed ID: 35103884
[TBL] [Abstract][Full Text] [Related]
5. QSP-IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno-Oncology Applications.
Sové RJ; Jafarnejad M; Zhao C; Wang H; Ma H; Popel AS
CPT Pharmacometrics Syst Pharmacol; 2020 Sep; 9(9):484-497. PubMed ID: 32618119
[TBL] [Abstract][Full Text] [Related]
6. FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspective.
Bai JPF; Schmidt BJ; Gadkar KG; Damian V; Earp JC; Friedrich C; van der Graaf PH; Madabushi R; Musante CJ; Naik K; Rogge M; Zhu H
AAPS J; 2021 Apr; 23(3):60. PubMed ID: 33931790
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
[TBL] [Abstract][Full Text] [Related]
8. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
Fleisher B; Brown AN; Ait-Oudhia S
Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
[TBL] [Abstract][Full Text] [Related]
9. A framework for simplification of quantitative systems pharmacology models in clinical pharmacology.
Derbalah A; Al-Sallami H; Hasegawa C; Gulati A; Duffull SB
Br J Clin Pharmacol; 2022 Feb; 88(4):1430-1440. PubMed ID: 32621550
[TBL] [Abstract][Full Text] [Related]
10. Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model.
Uatay A; Gall L; Irons L; Tewari SG; Zhu XS; Gibbs M; Kimko H
J Pharm Sci; 2024 Jan; 113(1):11-21. PubMed ID: 37898164
[TBL] [Abstract][Full Text] [Related]
11. Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
Agoram BM; Demin O
Drug Discov Today; 2011 Dec; 16(23-24):1031-6. PubMed ID: 22020181
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Systems Pharmacology: An Exemplar Model-Building Workflow With Applications in Cardiovascular, Metabolic, and Oncology Drug Development.
Helmlinger G; Sokolov V; Peskov K; Hallow KM; Kosinsky Y; Voronova V; Chu L; Yakovleva T; Azarov I; Kaschek D; Dolgun A; Schmidt H; Boulton DW; Penland RC
CPT Pharmacometrics Syst Pharmacol; 2019 Jun; 8(6):380-395. PubMed ID: 31087533
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm.
Chelliah V; Lazarou G; Bhatnagar S; Gibbs JP; Nijsen M; Ray A; Stoll B; Thompson RA; Gulati A; Soukharev S; Yamada A; Weddell J; Sayama H; Oishi M; Wittemer-Rump S; Patel C; Niederalt C; Burghaus R; Scheerans C; Lippert J; Kabilan S; Kareva I; Belousova N; Rolfe A; Zutshi A; Chenel M; Venezia F; Fouliard S; Oberwittler H; Scholer-Dahirel A; Lelievre H; Bottino D; Collins SC; Nguyen HQ; Wang H; Yoneyama T; Zhu AZX; van der Graaf PH; Kierzek AM
Clin Pharmacol Ther; 2021 Mar; 109(3):605-618. PubMed ID: 32686076
[TBL] [Abstract][Full Text] [Related]
14. Practical QSP application from the preclinical phase to enhance the probability of clinical success: Insights from case studies in oncology.
Oishi M; Sayama H; Toshimoto K; Nakayama T; Nagasaka Y
Drug Metab Pharmacokinet; 2024 Jun; 56():101020. PubMed ID: 38797089
[TBL] [Abstract][Full Text] [Related]
15. Applications of Quantitative System Pharmacology Modeling to Model-Informed Drug Development.
Zhu AZX; Rogge M
Methods Mol Biol; 2022; 2486():71-86. PubMed ID: 35437719
[TBL] [Abstract][Full Text] [Related]
16. [An introduction to QSP modeling for pharmacologists].
Sayama H; Nagasaka Y; Tabata K
Nihon Yakurigaku Zasshi; 2019; 154(3):143-150. PubMed ID: 31527365
[TBL] [Abstract][Full Text] [Related]
17. Applications of Quantitative Systems Pharmacology in Model-Informed Drug Discovery: Perspective on Impact and Opportunities.
Bradshaw EL; Spilker ME; Zang R; Bansal L; He H; Jones RDO; Le K; Penney M; Schuck E; Topp B; Tsai A; Xu C; Nijsen MJMA; Chan JR
CPT Pharmacometrics Syst Pharmacol; 2019 Nov; 8(11):777-791. PubMed ID: 31535440
[TBL] [Abstract][Full Text] [Related]
18. From data to QSP models: a pipeline for using Boolean networks for hypothesis inference and dynamic model building.
Putnins M; Campagne O; Mager DE; Androulakis IP
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):101-115. PubMed ID: 34988912
[TBL] [Abstract][Full Text] [Related]
19. Machine learning-guided, big data-enabled, biomarker-based systems pharmacology: modeling the stochasticity of natural history and disease progression.
McComb M; Blair RH; Lysy M; Ramanathan M
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):65-79. PubMed ID: 34611796
[TBL] [Abstract][Full Text] [Related]
20. Using quantitative systems pharmacology for novel drug discovery.
Pérez-Nueno VI
Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
